ARCHIVES

Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023

This article is from The Cancer Letter archive.

Vol. 39 No. 46 | December 13, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

Gemcitabine Improves DFS In Resected Pancreatic Cancer

June 24, 2005

Clinical Trials Approved By NCI Last Month

March 29, 2002

“Confidential and Proprietary” Document Proposes Plan for National Network

February 7, 2014

Schmitt To Chair Senate Health Appropriations Subcommittee

January 2, 1981